+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Barriers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 230 Pages
  • November 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 6027531
The global Skin Barriers Market is expected to grow from approximately USD 370.68 million in 2024 to USD 477.48 million by 2031, registering a CAGR of 3.6% during the forecast period. Increasing cases of urinary incontinence, ostomy surgeries, and advancements in skin barrier technologies are propelling the market’s growth worldwide.

The skin barriers market is witnessing growth driven by rising demand for advanced skin care solutions to address conditions like urinary incontinence, medical adhesive-related skin injuries, and pressure ulcers. Greater awareness and product availability in developing regions further bolster market expansion.

Key Drivers of Growth

1. Prevalence of Urinary Incontinence (UI)
  • Urinary incontinence remains a major contributor to market demand.
  • A global review reported that 37.1% of older women suffer from UI, with Asia reporting the highest prevalence at 45.1%.
2. Increase in Ostomy Surgeries
  • Over 1 million people in the U.S. currently live with an ostomy, with approximately 250,000 new surgeries annually, driving demand for skin barriers.
3. Addressing Medical Adhesive-Related Skin Injuries (MARSI)
  • MARSI is a preventable yet prevalent condition caused by excessive adhesive use. A study revealed 9.8% incidence per 100 medical adhesives and 36.4% incidence in surgical areas, underscoring the need for skin barrier products.
4. Moisture-Associated Skin Damage (MASD) and Pressure Ulcers
  • Skin barriers effectively prevent these conditions, particularly among hospitalized and elderly patients, fueling their adoption.
5. Strategic Mergers and Collaborations
  • Companies are forming strategic partnerships to enhance market reach. For example, Laboratoires Eriger partnered with Rahn Group for distribution of its Phytovec technology across key markets like the U.S., UK, and Germany.

Emerging Opportunities

1. Awareness Campaigns
  • Public initiatives, like Elvie’s #LeaksHappen campaign, are reducing the stigma around incontinence, driving product adoption.
  • These campaigns are particularly impactful in developing nations, where awareness about urinary incontinence is low.
2. Untapped Markets
  • In regions like Africa and Asia-Pacific, lack of access to incontinence products presents significant growth opportunities.
3. Preference for Natural Products
  • Markets like Germany are experiencing a rise in demand for skin barrier products made with natural ingredients, driven by consumer preferences for eco-friendly solutions.

Regional Insights

1. United States

The United States is a key player in the North American skin barrier market, driven by a growing aging population and advancements in bowel management devices. This demographic trend, coupled with ongoing R&D, continues to boost demand for advanced skin barrier solutions.

2. China

Skin barrier products are widely used in China due to varying skin traits influenced by climate and regional factors, such as UV damage in southern regions. Market growth is further supported by product approvals, including Sytheon’s Sytenol, the first bakuchiol-based product certified as a natural retinol alternative.

3. Japan

The skin barrier market in Japan is experiencing growth, driven by ongoing research and development efforts by manufacturers. Companies like Mary Kay Inc. have demonstrated a commitment to advancing skin science by participating in initiatives such as the Japanese Society of Investigative Dermatology's annual symposium, fostering collaboration and sharing breakthroughs in skin health technology.

4. United Kingdom

The United Kingdom is witnessing growing demand for skin barrier products, driven by the prevalence of urinary incontinence, particularly among women over 50. Skin barrier creams are increasingly recognized as effective solutions for managing related skin conditions, contributing to market growth in the region.

5. Germany

The German skin barrier market is growing as consumers increasingly prefer products with natural ingredients, valued for their efficacy in beauty and skincare. A willingness to invest in high-quality products further drives market expansion in the country.

Competitive Analysis

Leading companies in the skin barriers market are focusing on strategic acquisitions, partnerships, and product innovation to expand their market share.
  • Key Players:
  • Hollister Inc.
  • ConvaTech Inc
  • DermaRite Industries LLC
  • 3M
  • Coloplast Corp,
  • Stryker
  • Integra Lifesciences Corp
  • Smith & Nephew
  • GOJO Industries
  • Medlline Industries
  • B Braun Melsungen AG
  • Sonoma Pharmaceuticals Inc
  • Welland Medical Ltd.
  • Essity.

Skin Barriers Market Segmentation

Product:

  • Skin Barrier Sprays
  • Moisture Barrier Creams
  • Protective Ointments
  • Others

Indication:

  • Incontinence and Ostomy
  • Chronic Wounds
  • Pressure Ulcers
  • Skin Rash and Dry Skin
  • Atopic Dermatitis

Distribution:

  • Institutional Sales
  • Hospitals
  • Speciality Clinics
  • Long Term Care Centers
  • Skilled Nursing Facilities
  • Retail Sales
  • Retail Pharmacies
  • Drug Stores
  • Online Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Skin Barriers Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2024
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019 - 2023
3.2. Prominent Factor Affecting Skin Barriers Market Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Skin Barriers Market Outlook, 2019 - 2031
4.1. Global Skin Barriers Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1. Skin Barrier Sprays
4.1.1.2. Moisture Barrier Creams
4.1.1.3. Protective Ointments
4.1.1.4. Others
4.2. Global Skin Barriers Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Incontinence and Ostomy
4.2.1.2. Chronic Wounds
4.2.1.3. Pressure Ulcers
4.2.1.4. Skin Rash and Dry Skin
4.2.1.5. Atopic Dermatitis
4.3. Global Skin Barriers Market Outlook, by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Institutional Sales
4.3.1.1.1. Hospitals
4.3.1.1.2. Speciality Clinics
4.3.1.1.3. Long Term Care Centers
4.3.1.1.4. Skilled Nursing Facilities
4.3.1.2. Retail Sales
4.3.1.2.1. Retail Pharmacies
4.3.1.2.2. Drug Stores
4.3.1.2.3. Online Sales
4.4. Global Skin Barriers Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Skin Barriers Market Outlook, 2019 - 2031
5.1. North America Skin Barriers Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. Skin Barrier Sprays
5.1.1.2. Moisture Barrier Creams
5.1.1.3. Protective Ointments
5.1.1.4. Others
5.2. North America Skin Barriers Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Incontinence and Ostomy
5.2.1.2. Chronic Wounds
5.2.1.3. Pressure Ulcers
5.2.1.4. Skin Rash and Dry Skin
5.2.1.5. Atopic Dermatitis
5.3. North America Skin Barriers Market Outlook, by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Institutional Sales
5.3.1.1.1. Hospitals
5.3.1.1.2. Speciality Clinics
5.3.1.1.3. Long Term Care Centers
5.3.1.1.4. Skilled Nursing Facilities
5.3.1.2. Retail Sales
5.3.1.2.1. Retail Pharmacies
5.3.1.2.2. Drug Stores
5.3.1.2.3. Online Sales
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. North America Skin Barriers Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. U.S. Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.1.2. U.S. Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.1.3. U.S. Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.1.4. Canada Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.1.5. Canada Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.1.6. Canada Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Skin Barriers Market Outlook, 2019 - 2031
6.1. Europe Skin Barriers Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. Skin Barrier Sprays
6.1.1.2. Moisture Barrier Creams
6.1.1.3. Protective Ointments
6.1.1.4. Others
6.2. Europe Skin Barriers Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Incontinence and Ostomy
6.2.1.2. Chronic Wounds
6.2.1.3. Pressure Ulcers
6.2.1.4. Skin Rash and Dry Skin
6.2.1.5. Atopic Dermatitis
6.3. Europe Skin Barriers Market Outlook, by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Institutional Sales
6.3.1.1.1. Hospitals
6.3.1.1.2. Speciality Clinics
6.3.1.1.3. Long Term Care Centers
6.3.1.1.4. Skilled Nursing Facilities
6.3.1.2. Retail Sales
6.3.1.2.1. Retail Pharmacies
6.3.1.2.2. Drug Stores
6.3.1.2.3. Online Sales
6.3.2. Attractiveness Analysis
6.4. Europe Skin Barriers Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. Germany Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.2. Germany Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.3. Germany Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.4. U.K. Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.5. U.K. Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.6. U.K. Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.7. France Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.8. France Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.9. France Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.10. Italy Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.11. Italy Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.12. Italy Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.13. Turkey Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.14. Turkey Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.15. Turkey Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.16. Russia Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.17. Russia Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.18. Russia Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.19. Rest of Europe Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.20. Rest of Europe Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.1.21. Rest of Europe Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Skin Barriers Market Outlook, 2019 - 2031
7.1. Asia Pacific Skin Barriers Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. Skin Barrier Sprays
7.1.1.2. Moisture Barrier Creams
7.1.1.3. Protective Ointments
7.1.1.4. Others
7.2. Asia Pacific Skin Barriers Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Incontinence and Ostomy
7.2.1.2. Chronic Wounds
7.2.1.3. Pressure Ulcers
7.2.1.4. Skin Rash and Dry Skin
7.2.1.5. Atopic Dermatitis
7.3. Asia Pacific Skin Barriers Market Outlook, by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Institutional Sales
7.3.1.1.1. Hospitals
7.3.1.1.2. Speciality Clinics
7.3.1.1.3. Long Term Care Centers
7.3.1.1.4. Skilled Nursing Facilities
7.3.1.2. Retail Sales
7.3.1.2.1. Retail Pharmacies
7.3.1.2.2. Drug Stores
7.3.1.2.3. Online Sales
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Asia Pacific Skin Barriers Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. China Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.2. China Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.3. China Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.4. Japan Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.5. Japan Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.6. Japan Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.7. South Korea Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.8. South Korea Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.9. South Korea Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.10. India Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.11. India Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.12. India Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.13. Southeast Asia Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.14. Southeast Asia Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.15. Southeast Asia Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.16. Rest of Asia Pacific Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.17. Rest of Asia Pacific Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.1.18. Rest of Asia Pacific Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Skin Barriers Market Outlook, 2019 - 2031
8.1. Latin America Skin Barriers Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. Skin Barrier Sprays
8.1.1.2. Moisture Barrier Creams
8.1.1.3. Protective Ointments
8.1.1.4. Others
8.2. Latin America Skin Barriers Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.2.1.1. Incontinence and Ostomy
8.2.1.2. Chronic Wounds
8.2.1.3. Pressure Ulcers
8.2.1.4. Skin Rash and Dry Skin
8.2.1.5. Atopic Dermatitis
8.3. Latin America Skin Barriers Market Outlook, by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Institutional Sales
8.3.1.1.1. Hospitals
8.3.1.1.2. Speciality Clinics
8.3.1.1.3. Long Term Care Centers
8.3.1.1.4. Skilled Nursing Facilities
8.3.1.2. Retail Sales
8.3.1.2.1. Retail Pharmacies
8.3.1.2.2. Drug Stores
8.3.1.2.3. Online Sales
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Latin America Skin Barriers Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. Brazil Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.2. Brazil Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.3. Brazil Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.4. Mexico Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.5. Mexico Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.6. Mexico Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.7. Argentina Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.8. Argentina Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.9. Argentina Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.10. Rest of Latin America Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.11. Rest of Latin America Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.1.12. Rest of Latin America Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Skin Barriers Market Outlook, 2019 - 2031
9.1. Middle East & Africa Skin Barriers Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.1.1. Key Highlights
9.1.1.1. Skin Barrier Sprays
9.1.1.2. Moisture Barrier Creams
9.1.1.3. Protective Ointments
9.1.1.4. Others
9.2. Middle East & Africa Skin Barriers Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.2.1. Key Highlights
9.2.1.1. Incontinence and Ostomy
9.2.1.2. Chronic Wounds
9.2.1.3. Pressure Ulcers
9.2.1.4. Skin Rash and Dry Skin
9.2.1.5. Atopic Dermatitis
9.3. Middle East & Africa Skin Barriers Market Outlook, by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.3.1. Key Highlights
9.3.1.1. Institutional Sales
9.3.1.1.1. Hospitals
9.3.1.1.2. Speciality Clinics
9.3.1.1.3. Long Term Care Centers
9.3.1.1.4. Skilled Nursing Facilities
9.3.1.2. Retail Sales
9.3.1.2.1. Retail Pharmacies
9.3.1.2.2. Drug Stores
9.3.1.2.3. Online Sales
9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Middle East & Africa Skin Barriers Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1. Key Highlights
9.4.1.1. GCC Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.2. GCC Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.3. GCC Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.4. South Africa Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.5. South Africa Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.6. South Africa Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.7. Egypt Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.8. Egypt Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.9. Egypt Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.10. Nigeria Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.11. Nigeria Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.12. Nigeria Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.13. Rest of Middle East & Africa Skin Barriers Market by Product, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.14. Rest of Middle East & Africa Skin Barriers Market by Indication, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.1.15. Rest of Middle East & Africa Skin Barriers Market by Distribution, Value (US$ Mn) and Volume (Units), 2019 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Company Market Share Analysis, 2024
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. ConvaTec Inc.
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. Hollister Inc.
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. DermaRite Industries LLC
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. 3M
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. Coloplast Corp,
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Stryker
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. Integra Lifesciences Corp
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. Smith & Nephew
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. GOJO Industries
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
10.3.10. Others
10.3.10.1. Company Overview
10.3.10.2. Product Portfolio
10.3.10.3. Financial Overview
10.3.10.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Hollister Inc.
  • ConvaTech Inc
  • DermaRite Industries LLC
  • 3M
  • Coloplast Corp,
  • Stryker
  • Integra Lifesciences Corp
  • Smith & Nephew
  • GOJO Industries
  • Medlline Industries
  • B Braun Melsungen AG
  • Sonoma Pharmaceuticals Inc
  • Welland Medical Ltd.
  • Essity.

Methodology

Loading
LOADING...